课题基金 / 基金详情

Study on gene expression control and pathophysiological mechanism of red cell membrane protein 4.2 in normal and disorders of hereditary hemolytic anemia

Study on gene expression control and pathophysiological mechanism of red cell membrane protein 4.2 in normal and disorders of hereditary hemolytic anemia
遗传性溶血性贫血正常及异常状态下红细胞膜蛋白4.2基因表达调控及病理生理机制研究
批准号:
09670164
负责人:
KANZAKI Akio
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

KANZAKI Akio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The following results were obtained for the recent two years (1997-1999)1.Protein 4.2 (P4.2) anomalies in heredirary hemolytic anemia P4.2 anomalies were identified by quantitative membrane protein analysis from 179 patients in 8Okindreds with hereditary hemolytic anemias. These cases were divided into two types ; i.e., (1) a qualitative anomaly (P4.2 doublet Nagano), and (2) a quantitative anomaly. In qualitative P4.2 anomaly, a point mutation (R488H) was identified on the P4.2 gene in P4.2 doublet Nagano with abnormal P4.2 (72/74kD). In quantitative P4.2 anomalies, mutant genes were detected ; i.e., (1) Mild to moderate P4.2 deficiencies : B3 Fukuoka : G 130R, B3 Kagoshima : 56, 1 nt. del. , B3 Fukuyama I : 112-113, 2nt. del., B3 Fukuyama II : 183, 1 nt. ins., B3 Yamagata : G455R, B3 Okinawa : G714R, B3 Tochigi : R760W, 83 IKumamoto : R760Q B3 Nara : R808H, B3 Nagoya : T837R, B3 Philadelphia : T837M, all mutations were detected on B3 gene. (2) P4.2 complete deficiency : P4.2 mutation … More of the Nippon type (A 142T).2.P4.2 expression in human erythroblasts The expression of P4.2 in normal human erythroid cells was studied utilizing erythroblasts(Ebl) from bone marrow and cultured erythroid cells. P4.2 was first detected in orthochromatic Ebl. Among the various major membrane proteins, the expression of P4.2 was the latest. P4.2 gene mRNA was expressed in early Ebl. During normal erythroid maturation, the expression of seven different P4.2 gene products was observed by Southern blot analysis. Therefore, it can be speculated that P4.2 is expressed after the cytoskeletal network has been constructed and assembled with integral proteins in the membrane lipid bilayer.3.The methylation status of the promoter region of the band3(B3)gene in P4.2 complete deficiency Normally, the 15 CpG sites in the promoter region were almost fully methylated in the B3 gene. In contrast, in P4.2 complete deficiency, three distinct CpG sites(G,K &L) were totally or nearly totally unmethylated in the B3 genes.Although no significant changes of the status of methylation were observed in P4.2 genes.Therefore, the state of methylation might be altered in the disease states probably by changes of the comformation of the DNAs. Less
期刊论文(49)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Inoue,T.: "Homozygous missense mutation (band 3 Fukuoka:G130R):a mild form of hereditary spherocytosis with near-normal band 3 bontent and minimal changes of membrane ultrastructure despite moderate protein 4.2 deficiency." Brit.J.Haematol.102. 932-939 (1
Inoue,T.:“纯合错义突变(带 3 福冈:G130R):一种轻度形式的遗传性球形红细胞增多症,尽管存在中度蛋白质 4.2 缺陷,但带 3 的强度接近正常,膜超微结构的变化最小。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ayumi Yawata: "A Markedly Disrupted Skeletal Network With Abnormally Distributed Intramembrane Particles in Complete Protein 4.1-Deficient Red Blood Cells(Allele 4.1 Madrid):Implication Regarding a Critical Role of Protein 4.1 in Maintenance of the Integr
Ayumi Yawata:“完全蛋白质 4.1 缺陷的红细胞(等位基因 4.1 马德里)中的骨骼网络显着破坏,膜内颗粒分布异常:关于蛋白质 4.1 在维持完整性中的关键作用的暗示
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
42
    Molecular biochemistry and electron microscopy in normal and abnormal human red cell membrane protein 4.2
    • 批准号:
      07670180
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.47万
    • 财政年份:
      1995
    • 负责人:
      KANZAKI Akio
    • 依托单位:
    国内基金
    海外基金
    骨关节炎中白血病抑制因子isoform1/isoform2比例倒置破坏抗氧化防御系统稳态促进调节性软骨细胞铁死亡的机制研究
    • 批准号:
      JCZRLH202601914
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    NEK2新转录本isoform3在核内调控胃癌细胞转移的分子机制研究
    • 批准号:
      LBY21H160004
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑晶晶
    • 依托单位:
    基于三代测序全长转录组的特异性Isoform识别方法研究及特征分析
    • 批准号:
      31760316
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      35.0万元
    • 批准年份:
      2017
    • 负责人:
      谢尚潜
    • 依托单位:
    非编码RNA介导的全局isoform网络构建及遗传效应驱动的肿瘤预后通路区域和标志物识别研究
    • 批准号:
      31701145
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      25.0万元
    • 批准年份:
      2017
    • 负责人:
      张春龙
    • 依托单位: